MAP
Moody Aldrich Partners Portfolio holdings
AUM
$517M
This Quarter Return
+16.87%
1 Year Return
+38.15%
3 Year Return
+181.18%
5 Year Return
+335.56%
10 Year Return
–
AUM
$588M
AUM Growth
+$588M
(+5.7%)
Cap. Flow
-$14.5M
Cap. Flow
% of AUM
-2.46%
Top 10 Holdings %
Top 10 Hldgs %
17.49%
Holding
244
New
49
Increased
44
Reduced
112
Closed
29
Top Buys
| 1 |
Modine Manufacturing
MOD
|
$6.67M |
| 2 |
Halozyme
HALO
|
$5.04M |
| 3 |
AppFolio
APPF
|
$4.84M |
| 4 |
Viking Therapeutics
VKTX
|
$4.57M |
| 5 |
Fabrinet
FN
|
$4.15M |
Top Sells
| 1 |
Super Micro Computer
SMCI
|
$8.47M |
| 2 |
The Bancorp
TBBK
|
$7.18M |
| 3 |
CBAY
Cymabay Therapeutics
CBAY
|
$6.17M |
| 4 |
Asbury Automotive
ABG
|
$5.91M |
| 5 |
ESCO Technologies
ESE
|
$4.49M |
Sector Composition
| 1 | Healthcare | 17.82% |
| 2 | Industrials | 15.19% |
| 3 | Consumer Discretionary | 13.61% |
| 4 | Financials | 13.51% |
| 5 | Technology | 13.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Coterra Energy
CTRA
$18.4B
| $1.85M | 0.32% |
+66,529
| New | +$1.85M |
|
102
Aflac
AFL
$57.1B
| $1.85M | 0.31% |
+21,509
| New | +$1.85M |
|
103
Synchrony
SYF
$28.1B
| $1.83M | 0.31% |
42,470
-13,244
| -24% | -$571K |
|
|
DFS
104
DELISTED
Discover Financial Services
DFS
| $1.83M | 0.31% |
13,923
| – | – |
|
105
AbbVie
ABBV
$374B
| $1.79M | 0.31% |
9,847
+321
| +3% | +$58.5K |
|
106
Alkermes
ALKS
$4.95B
| $1.79M | 0.3% |
66,208
+13,638
| +26% | +$369K |
|
107
Braze
BRZE
$2.85B
| $1.79M | 0.3% |
+40,369
| New | +$1.79M |
|
108
Regeneron Pharmaceuticals
REGN
$59.8B
| $1.79M | 0.3% |
1,856
-137
| -7% | -$132K |
|
109
Best Buy
BBY
$15.8B
| $1.69M | 0.29% |
20,661
| – | – |
|
110
Biohaven
BHVN
$1.71B
| $1.67M | 0.28% |
+30,547
| New | +$1.67M |
|
111
Signet Jewelers
SIG
$3.65B
| $1.6M | 0.27% |
15,994
-8,403
| -34% | -$841K |
|
112
Power Integrations
POWI
$2.46B
| $1.54M | 0.26% |
21,571
-5,996
| -22% | -$429K |
|
113
Arrowhead Research
ARWR
$3.84B
| $1.52M | 0.26% |
53,039
-1,055
| -2% | -$30.2K |
|
114
Arcellx
ACLX
$3.95B
| $1.43M | 0.24% |
+20,560
| New | +$1.43M |
|
115
Madrigal Pharmaceuticals
MDGL
$9.7B
| $1.37M | 0.23% |
5,124
-4,099
| -44% | -$1.09M |
|
116
Microsoft
MSFT
$3.76T
| $1.35M | 0.23% |
3,217
-1,158
| -26% | -$487K |
|
117
NVIDIA
NVDA
$4.15T
| $1.18M | 0.2% |
1,306
-251
| -16% | -$227K |
|
118
Silicon Laboratories
SLAB
$4.3B
| $1.16M | 0.2% |
8,098
-9,883
| -55% | -$1.42M |
|
119
Vertex Pharmaceuticals
VRTX
$102B
| $1.16M | 0.2% |
2,764
+423
| +18% | +$177K |
|
120
Eli Lilly
LLY
$661B
| $1.03M | 0.17% |
1,321
-442
| -25% | -$344K |
|
121
Amgen
AMGN
$153B
| $910K | 0.15% |
3,202
-1
| -0% | -$284 |
|
|
SWTX
122
DELISTED
SpringWorks Therapeutics
SWTX
| $890K | 0.15% |
+18,080
| New | +$890K |
|
123
Kinsale Capital Group
KNSL
$10.5B
| $825K | 0.14% |
1,573
+269
| +21% | +$141K |
|
124
United Therapeutics
UTHR
$17.7B
| $798K | 0.14% |
3,475
+1,451
| +72% | +$333K |
|
125
Merck
MRK
$210B
| $760K | 0.13% |
5,760
-1,929
| -25% | -$255K |
|